MAP1LC3A and injury: It is recognized that frequent Ket administration reduces the expression of autophagy proteins, such as LC3, in rat models of traumatic brain injury, probably by activating the mTOR signaling pathway [86], and indeed, Ket has been described as activating mTOR signaling in mammals [84], which is a key regulator of cell growth and proliferation.